The Europe Minimally Invasive Surgical Instruments Market was valued at $7388.2 Million in 2024 and projected to reach to $11116.9 Million by 2029, representing a compound annual growth rate of 8.5%. Europe's minimally invasive surgical instruments market is poised for steady expansion through 2029, supported by an aging population requiring surgical interventions and continuous technological advancements in instrument design.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Europe commands a significant share of the global minimally invasive surgical instruments market, valued at USD 7,388.2 million in 2024, driven by advanced healthcare systems and high surgical procedure volumes across the region.
Europe's rapidly aging demographic profile is a key growth driver, with increasing prevalence of chronic diseases requiring surgical intervention, particularly in countries like Germany, UK, and France.
Strong healthcare spending, regulatory frameworks, and hospital modernization initiatives across European nations support widespread adoption of minimally invasive technologies and premium surgical instruments.
The European market is projected to reach USD 11,116.9 million by 2029 at a CAGR of 8.5%, reflecting sustained investment in surgical innovation and increasing patient preference for less invasive procedures.
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | ROBOTIC INSTRUMENTS (Product) |
| Forecast Period | 2024-2029 |
| Growth Rate | CAGR of 9.5% from 2024 to 2029 |
| Largest Segment | NON-ROBOTIC SURGERY (Technology) |
| Market Size Base Year (Billions) | ~USD 31.7 (2024) |
| Revenue Forecast (Billions) | ~USD 49.9 (2029) |
| Segments Covered | Product, Type, Technology, Type Of Surgery, End User |
5 segment dimensions are covered across the global market.
| Segment | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| AMBULATORY SURGERY CENTERS | 2097.7 | 2182.6 | 2339.8 | 2514.9 | 2710.1 | 2928 | 3168.7 | 3444.4 | 8 |
| HOSPITALS & SPECIALTY CLINICS | 4468.7 | 4679.3 | 5048.4 | 5460.8 | 5922.2 | 6439.4 | 7013.5 | 7672.5 | 8.7 |
| TOTAL | 6566.4 | 6861.9 | 7388.2 | 7975.6 | 8632.3 | 9367.4 | 10182.2 | 11116.9 | 8.5 |
| Segment | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| AMBULATORY SURGERY CENTERS | 420.3 | 440.1 | 474.7 | 513.5 | 556.7 | 605.2 | 659 | 720.8 | 8.7 |
| HOSPITALS & SPECIALTY CLINICS | 950.1 | 999.5 | 1083.3 | 1177.2 | 1282.5 | 1400.8 | 1532.6 | 1684.1 | 9.2 |
| TOTAL | 1370.5 | 1439.6 | 1558.1 | 1690.7 | 1839.3 | 2006.1 | 2191.6 | 2404.9 | 9.1 |
| Country | 2025 size (native) |
|---|---|
| Germany | USD 3047.5 Million |
| UK | USD 2265.4 Million |
| France | USD 323.3 Million |
| Italy | USD 234.7 Million |
| Spain | USD 204.2 Million |
| Rest Of Europe | USD 523.1 Million |
Europe's minimally invasive surgical instruments market was valued at USD 7,388.2 million in 2024 and is expected to grow to USD 11,116.9 million by 2029.
Europe's minimally invasive surgical instruments market is projected to grow at a compound annual growth rate (CAGR) of 8.5% from 2024 to 2029.
Key growth drivers in Europe include an aging population, advanced healthcare infrastructure, high healthcare spending, strong regulatory frameworks, and increasing adoption of robotic-assisted and digital surgical technologies.
Cardiology, orthopedics, and general surgery are among the leading specialties driving demand for minimally invasive instruments across Europe.
Europe's 8.5% CAGR is slightly below the global average of 9.5%, reflecting Europe's mature healthcare market and established adoption of minimally invasive techniques.
The objective of the study is analyzing the key market dynamics such as drivers, opportunities, challenges, restraints, and key player strategies. To track companies’ developments such as product launch, approval, acquisition, agreement and expansion of the leading players, the competitive landscape of the minimally invasive surgical instruments market to analyzes market players on various parameters within the broad categories of business and product strategy. Top-down and bottom-up approaches were used to estimate the market size. To estimate the market size of segments and subsegments the market breakdown and data triangulation were used.
The four steps involved in estimating the market size are
In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify the critical qualitative and quantitative information as well as assess prospects.
The following is a breakdown of the primary respondents:

Note 1: Others include sales managers, marketing managers, and product managers.
Note 2: Companies are classified into tiers based on their total revenues. As of 2022, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = <USD 10 million.
To know about the assumptions considered for the study, download the pdf brochure
|
COMPANY NAME |
DESIGNATION |
|
Medtronic PLC (US) |
Marketing Manager |
|
Johnson & Johnson (US) |
Senior Product Manager |
|
Intuitive Surgical Inc. (US) |
Marketing Manager |
Both top-down and bottom-up approaches were used to estimate and validate the home healthcare market's total size. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

To know about the assumptions considered for the study, Request for Free Sample Report

After arriving at the overall market size applying the process mentioned above, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Minimally invasive surgery (MIS) is a surgical procedure done in a manner that causes little to no trauma or injury to a patient. MIS is executed through a cannula using lasers, endoscopes or laparoscopes. MIS involves less bleeding, smaller amounts of anesthesia, less pain, and minimal scarring than other procedures. The surgical instruments used to make minute incisions in the body and perform MIS procedures are minimally invasive.
MarketsandMarkets offers the following customizations for this market report
Full forecast, segment splits, and company analysis for all Minimally Invasive Surgical Instruments Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report